<DOC>
	<DOC>NCT00186238</DOC>
	<brief_summary>To assess the role of autologous hematopoietic cell rescue in the treatment of multiple myeloma.</brief_summary>
	<brief_title>High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma</brief_title>
	<detailed_description>To assess the toxicity and efficacy of sequentially administered high dose cyclophosphamide and VP-16 followed by total body irradiation or BCNU and high dose mephalan and autologous stem cell rescue in the treatment of multiple myeloma.</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms, Plasma Cell</mesh_term>
	<criteria>received cytoreduction prior to transplant adequate organ function previous transplant smoldering MM or benign monoclonal gammopathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2010</verification_date>
</DOC>